Skip to main content
Premium Trial:

Request an Annual Quote

Science's Hedge Fund Problem

The New England Journal of Medicine and other journals may soon require that researchers tell editors of any payments they've received from hedge funds before their work is published, says Bloomberg News' Alex Nussbaum. Existing rules on disclosing payments from drug and device companies don't cover investor money, Nussbaum says, and editors from NEJM, JAMA, and 12 others are getting together in June to talk about how to rectify this omission. The issue surfaced in November when French researcher Yves Benhamou leaked information about a drug study being conducted by Human Genome Sciences — the company he was advising at the time — to a hedge fund investing in the company, Nussbaum says.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.